Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health.
Gostin
Lawrence O
LO
O'Neill Institute for National and Global Health Law, Georgetown University, Washington, DC 20001, USA. gostin@law.georgetown.edu
D017277:Drug Approval / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000331:legislation & jurisprudence; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D064420:Drug-Related Side Effects and Adverse Reactions; D035082:Federal Government; D006801:Humans; D007880:Legislation, Drug; D016365:Liability, Legal; D004364:Pharmaceutical Preparations / Q000592:standards; D011634:Public Health / Q000331:legislation & jurisprudence; D013219:State Government; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D004364:Pharmaceutical Preparations